Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TEKT4P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RTCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC339978 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRG1JP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCERG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507564 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF611 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITSN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCT6P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACSS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on